Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Limited Access to Ultrasound Impedes Efforts to Help Prevent Pediatric Stroke

By HospiMedica International staff writers
Posted on 05 May 2009
The number of children with a specific blood disorder undergoing an ultrasound to help prevent stroke has increased significantly in the past 10 years since a major study demonstrated its benefits. More...
However, limited access to labs that perform this type of screening appears to be an obstacle to helping these children who are at a high risk of stroke.

In the study, published in the April 14, 2009, issue of the journal Neurology, the researchers tracked 157 children with sickle cell disease in northern California (USA) for an average of 8.5 years. Sickle cell disease is a lifelong blood disorder that increases a child's risk of stroke. Approximately 1 child out of 10 with the disease suffers a stroke by age 20.

For the study, researchers determined how many children underwent a transcranial Doppler ultrasound (TCD) screening since 1998, when a key study, known as the STOP (Stroke Prevention Trial in Sickle Cell Anemia) trial, was published. The STOP trial revealed a more than 90% reduction in the stroke rate of children with sickle cell disease who received a TCD screening and were identified as having a high risk of stroke and could therefore have blood transfusion therapy.

Since the STOP trial, the current study found the rate of TCD screening among children with sickle cell disease has increased six-fold while the yearly stroke rate has decreased by more than half. However, researchers found children living farther away from a vascular laboratory were less likely to be screened. "Stroke in children with sickle cell disease should be a largely preventable disease, however, not all children at risk are getting screened," said Heather J. Fullerton, M.D., MAS, from the University of California, San Francisco (UCSF; USA). "Limited access to labs that perform TCD screening, even among kids with comprehensive health insurance, appears to be a barrier to helping these kids reduce their high risk of stroke. Increased availability of these screening labs may help prevent stroke in these high risk children."

Guidelines from the American Academy of Neurology (St. Paul, MN, USA) recommend TCD screening of children with sickle cell disease beginning at age two.

Related Links:

University of California, San Francisco




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Digital Radiography System (Ceiling Free)
Digix CF Series
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.